Jiangfeng Hu

838 total citations
27 papers, 586 citations indexed

About

Jiangfeng Hu is a scholar working on Molecular Biology, Cancer Research and Aerospace Engineering. According to data from OpenAlex, Jiangfeng Hu has authored 27 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cancer Research and 5 papers in Aerospace Engineering. Recurrent topics in Jiangfeng Hu's work include MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (8 papers) and Cancer-related molecular mechanisms research (6 papers). Jiangfeng Hu is often cited by papers focused on MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (8 papers) and Cancer-related molecular mechanisms research (6 papers). Jiangfeng Hu collaborates with scholars based in China, Germany and Australia. Jiangfeng Hu's co-authors include Yang Jiang, Zhitao Jing, Junshuang Zhao, Jinpeng Zhou, Haiying Zhang, Hong Chen, Jiyi Zhao, Zhenlin Wang, Chenting Ying and Dan Zou and has published in prestigious journals such as Oncogene, International Journal of Cancer and Sustainability.

In The Last Decade

Jiangfeng Hu

22 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangfeng Hu China 14 396 350 61 59 48 27 586
Yu Peng China 14 286 0.7× 191 0.5× 86 1.4× 85 1.4× 38 0.8× 39 460
Alexandru Tirpe Romania 8 214 0.5× 203 0.6× 67 1.1× 81 1.4× 57 1.2× 13 461
Chenghao Wang China 11 357 0.9× 261 0.7× 65 1.1× 106 1.8× 40 0.8× 34 599
Yusheng Wang China 13 276 0.7× 200 0.6× 45 0.7× 61 1.0× 52 1.1× 36 527
Xiangsheng Yang China 14 345 0.9× 146 0.4× 43 0.7× 51 0.9× 40 0.8× 25 526
Qingsheng Xu China 10 200 0.5× 194 0.6× 75 1.2× 40 0.7× 46 1.0× 30 417
Z Liu China 10 395 1.0× 222 0.6× 59 1.0× 157 2.7× 44 0.9× 25 717
Xianchun Yan China 13 305 0.8× 161 0.5× 64 1.0× 87 1.5× 95 2.0× 27 569

Countries citing papers authored by Jiangfeng Hu

Since Specialization
Citations

This map shows the geographic impact of Jiangfeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangfeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangfeng Hu more than expected).

Fields of papers citing papers by Jiangfeng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangfeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangfeng Hu. The network helps show where Jiangfeng Hu may publish in the future.

Co-authorship network of co-authors of Jiangfeng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangfeng Hu. A scholar is included among the top collaborators of Jiangfeng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangfeng Hu. Jiangfeng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Hu, Jiangfeng, et al.. (2025). Predicting survival rates: the power of prognostic nomograms in distal cholangiocarcinoma. Frontiers in Oncology. 15. 1478836–1478836.
4.
5.
Li, Shilun, Yixiao Pan, Weiyu Zhang, et al.. (2025). Exosome-hybridized hydrogel acts as a foamy protective coat for the liver. Chinese Chemical Letters. 36(11). 110841–110841.
6.
7.
Dong, Yuwei, et al.. (2021). miR-369 inhibits Liver Cancer progression by targeting ZEB1 pathway and predicts the prognosis of HCC patients. Journal of Cancer. 12(10). 3067–3076. 12 indexed citations
8.
Wang, Zhenlin, et al.. (2021). Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling. Oncogene. 40(8). 1458–1475. 42 indexed citations
9.
Jiang, Yang, Jinpeng Zhou, Junshuang Zhao, et al.. (2020). The U2AF2 /circRNA ARF1/miR-342–3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells. Journal of Experimental & Clinical Cancer Research. 39(1). 182–182. 83 indexed citations
10.
Jiang, Yang, Jinpeng Zhou, Junshuang Zhao, et al.. (2020). MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-α-mediated NF-κB signaling pathway. EBioMedicine. 52. 102651–102651. 55 indexed citations
11.
Zhou, Jinpeng, Yang Jiang, Junshuang Zhao, et al.. (2020). Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma. Cellular Oncology. 43(3). 461–475. 43 indexed citations
12.
Jiang, Yang, Jinpeng Zhou, Dan Zou, et al.. (2019). Overexpression of Limb-Bud and Heart (LBH) promotes angiogenesis in human glioma via VEGFA-mediated ERK signalling under hypoxia. EBioMedicine. 48. 36–48. 50 indexed citations
13.
Duan, Bensong, Jiangfeng Hu, Xu Luo, et al.. (2017). miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation. BMC Gastroenterology. 17(1). 12–12. 22 indexed citations
14.
Lin, Maosong, Bensong Duan, Jiangfeng Hu, et al.. (2017). Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer. Oncology Letters. 14(1). 1061–1067. 24 indexed citations
15.
Hu, Jiangfeng, Chenlin Song, Bensong Duan, et al.. (2017). LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma. Oncotarget. 8(58). 97835–97850. 18 indexed citations
16.
Duan, Bensong, Jiangfeng Hu, Hongliang Liu, et al.. (2017). Genetic variants in the platelet‐derived growth factor subunit B gene associated with pancreatic cancer risk. International Journal of Cancer. 142(7). 1322–1331. 17 indexed citations
17.
Hu, Jiangfeng, Chao Chen, Qidong Liu, et al.. (2015). The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis. Clinical Science. 129(4). 305–317. 49 indexed citations
18.
Chen, Chao, Peng Hou, Songcheng Zhu, et al.. (2014). Overexpression of miR-126 Inhibits the Activation and Migration of HSCs through Targeting CRK. Cellular Physiology and Biochemistry. 33(1). 97–106. 18 indexed citations
19.
Hu, Jiangfeng, Xiaocheng Zhu, Huajiang Ouyang, et al.. (2013). The unsteadiness of tip clearance flow and its effect to stability of transonic axial compressor. Journal of Theoretical and Applied Mechanics/Mechanika Teoretyczna i Stosowana. 51(2). 431–438. 4 indexed citations
20.
Zhu, Xiaocheng, et al.. (2013). THE OFF-DESIGN PERFORMANCE PREDICTION OF AXIAL COMPRESSOR BASED ON A 2D APPROACH. Journal of Theoretical and Applied Mechanics/Mechanika Teoretyczna i Stosowana. 51(3). 523–531. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Peng Breakdown of academic impact, for papers by Alexandru Tirpe Breakdown of academic impact, for papers by Chenghao Wang Breakdown of academic impact, for papers by Yusheng Wang Breakdown of academic impact, for papers by Xiangsheng Yang Breakdown of academic impact, for papers by Qingsheng Xu Breakdown of academic impact, for papers by Z Liu Breakdown of academic impact, for papers by Xianchun Yan
Rankless by CCL
2026